Table 2 Treatment and response to AEDs at initial visit and 2- years after among the study group (n = 202)
Initial Visit | After 2 years | |
|---|---|---|
Anti-Epileptic Drugs (AEDs)Treatment | ||
Mono therapy | 170(84.2%) | 150(76.7%) |
Two drugs | 30(14.8%) | 36(17.8%) |
polytherapy | 02(1.0%) | 10(4.0%) |
Anti-Epileptic Drugs (AEDs) | ||
Sodium Valproate | 130 (64.3%) | 90(44.5%) |
Carbamazepine | 87(43.0%), | 60(29.7%) |
Lamotrigene | 0.0 | 40(19.8%) |
Levetiracetam | 0.0 | 57(28.2%) |
Phenbarbitone | 19 (9.4%) | 0.0 |
Topiramate | 04 (1.9%) | 0.0 |
Others | 04(1.9%) | 15(7.4%) |
Response to AEDS | ||
Fully recovered | 0.0 | 15(7.4) |
Good control | 42 (20.8) | 165(81.7) |
Partially control | 50(24.7) | 20(9.9) |
Uncontrolled | 110(54.4) | 02(1.0%) |
Total | 202(100) | 202(100) |